Ah receptor agonists as endocrine disruptors: Antiestrogenic activity and mechanisms

Toxicology Letters

Volumn 102-103, Issue , 1998, Pages 343-347

  Safe, S ^a   Wang, F ^a   Porter, W ^a   Duan, R ^a   McDougal, A ^a  

^a TEXAS A AND M UNIVERSITY   (United States)

Author keywords

2,3,7,8 Tetrachlorodibenzo p dioxin; Ah receptor; Antiestrogens; Antitumor agents; Endocrine disruptors

Indexed keywords

2,3,7,8 TETRACHLORODIBENZO PARA DIOXIN; ANTIESTROGEN; AROMATIC HYDROCARBON RECEPTOR; ESTROGEN RECEPTOR; HEAT SHOCK PROTEIN 27; PROGESTERONE RECEPTOR;

ANIMAL CELL; ANIMAL MODEL; BREAST CANCER; BREAST TUMOR; CONFERENCE PAPER; CONTROLLED STUDY; ENDOCRINE DISEASE; GENE EXPRESSION; HUMAN; HUMAN CELL; IN VITRO STUDY; MOUSE; NONHUMAN; PRIORITY JOURNAL; RAT; SIGNAL TRANSDUCTION; UTERUS;

ANIMALS; BREAST NEOPLASMS; ENDOCRINE GLANDS; ESTROGEN ANTAGONISTS; FEMALE; HUMANS; MICE; RATS; RECEPTORS, ARYL HYDROCARBON; TETRACHLORODIBENZODIOXIN;

RODENTIA;

EID: 0032420358     PISSN: 03784274     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0378-4274(98)00331-2     Document Type: Conference Paper

References (13)

1. Chen, I., McDougal, A., Wang, F., Safe, S., 1998. Aryl hydrocarbon receptor-mediated antiestrogenic and antitumorigenic activity of diindolylmethane. Carcinogenesis 19, 1631-1639.
2. Gierthy, J.F., Lincoln, D.W., Gillespie, M.B., et al., 1987. Suppression of estrogen-regulated extracellular plasminogen activator activity of MCF-7 cells by 2,3,7,8-tetrachlorodibenzo-p-dioxin. Cancer Res. 47, 6198-6203.
3. Gierthy, J.F., Bennett, J.A., Bradley, L.M., Cutler, D.S., 1993. Correlation of in vitro and in vivo growth suppression of MCF-7 human breast cancer by 2,3,7,8-tetrachlorodibenzo-p-dioxin. Cancer Res. 53, 3149-3153.
4. Gillesby, B., Santostefano, M., Porter, W., Wu, Z.F., Safe, S., Zacharewski, T., 1997. Identification of a motif within the 5′-regulatory region on pS2 which is responsible for Ap1 binding and TCDD-mediated suppression. Biochemistry 36, 6080-6089.
5. Holcomb, M., Safe, S., 1994. Inhibition of 7,12-dimethylbenzanthracene-induced rat mammary tumor growth by 2,3,7,8-tetrachlorodibenzo-p-dioxin. Cancer Lett. 82, 43-47.
6. Kociba, R.J., Keyes, D.G., Beger, J.E., et al., 1978. Results of a 2-year chronic toxicity and oncogenicity study of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) in rats. Toxicol. Appl. Pharmacol. 46, 279-303.
7. Krishnan, V., Porter, W., Santostefano, M., Wang, X., Safe, S., 1995. Molecular mechanism of inhibition of estrogen-induced cathepsin D gene expression by 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) in MCF-7 cells. Mol. Cell. Biol. 15, 6710-6719.
8. McDougal, A., Wilson, C., Safe, S., 1997. Inhibition of 7,12-dimethylbenz[a]anthracene-induced rat mammary tumor growth by aryl hydrocarbon receptor agonists. Cancer Lett. 120, 53-63.
9. Poland, A., Glover, E., Kende, A.S., 1976. Stereospecific, high affinity binding of 2,3,7,8-tetrachlorodibenzo-p-dioxin by hepatic cytosol: evidence that the binding species is receptor for induction of aryl hydrocarbon hydroxylase. J. Biol. Chem. 251, 4936-4946.
10. Safe, S., 1995. Modulation of gene expression and endocrine response pathways by 2,3,7,8-tetrachlorodibenzo-p-dioxin and related compounds. Pharmacol. Therap. 67, 247-281.
11. Tritscher, A.M., Clark, G.C., Sewall, C., Sills, R.C., Maronpot, R., Lucier, G.W., 1995. Persistence of TCDD-induced hepatic cell proliferation and growth of enzyme altered foci after chronic exposure followed by cessation of treatment in DEN initiated female rats. Carcinogenesis 16, 2807-2811.
12. Wang, W., Porter, W., Burghardt, R., Safe, S., 1997. Mechanism of inhibition of MDA-MB-468 breast cancer cell growth by 2,3,7,8-tetrachlorodibenzo-p-dioxin. Carcinogenesis 18, 925-933.
13. Whitlock, J.P., Jr., 1993. Mechanistic aspects of dioxin action. Chem. Res. Toxicol. 6, 754-763.